Sylvant 400 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZ1QX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,545
Award facts
- Contract value 100% obligated
- $23,545.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $23,545.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sylvant 400 mg vials, with a completion deadline of October 20, 2025. This contract, issued on September 26, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive $1 billion pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated its capability to meet federal requirements through consistent competitive awards across multiple therapeutic domains. The company serves key federal customers including the Defense Health Agency and U.S. Coast Guard through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. As a child contract under the SPE2DX prime IDV, this delivery order exemplifies the contractor's role in supplying specialized pharmaceutical products necessary for military healthcare operations, with the DLA planning to expand its pharmaceutical procurement strategy through generation V contracts with multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FZ1QX?
SPE2DB25FZ1QX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FZ1QX worth?
The government has obligated $23,545 on SPE2DB25FZ1QX.
Is contract SPE2DB25FZ1QX an order under another contract?
Yes. SPE2DB25FZ1QX is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1QX competed?
The extent of competition for SPE2DB25FZ1QX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award